Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation
Faizul Azam, Eltayeb E. M. Eid, Abdulkarim Almutairi
Journal of Molecular Structure (2021) Vol. 1246, pp. 131124-131124
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Muhammed Tılahun Muhammed, Esin Aki
Letters in Drug Design & Discovery (2022) Vol. 21, Iss. 3, pp. 480-495
Closed Access | Times Cited: 79
COVID-19 Therapeutic Options Under Investigation
Malak Kaddoura, Malak Al Ibrahim, Ghina Hijazi, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 83
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
Praveen Tripathi, Saurabh Upadhyay, Manju Rawat Singh, et al.
International Journal of Biological Macromolecules (2020) Vol. 164, pp. 2622-2631
Open Access | Times Cited: 53
Microbial-based natural products as potential inhibitors targeting DNA gyrase B of Mycobacterium tuberculosis: an in silico study
Tilal Elsaman, Magdi Awadalla Mohamed, Malik Suliman Mohamed, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia
Suliman A. Alsagaby, Danish Iqbal, Iqrar Ahmad, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
In vitro and in silico evaluations of actinomycin X2and actinomycin D as potent anti-tuberculosis agents
Kamal A. Qureshi, Faizul Azam, M. Qaiser Fatmi, et al.
PeerJ (2023) Vol. 11, pp. e14502-e14502
Open Access | Times Cited: 10
Flavonostilbenes natural hybrids from Rhamnoneuron balansae as potential antitumors targeting ALDH1A1: molecular docking, ADMET, MM-GBSA calculations and molecular dynamics studies
Tilal Elsaman, Iqrar Ahmad, Eyman Mohamed Eltayib, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 6, pp. 3249-3266
Closed Access | Times Cited: 10
Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety
Ansari Vikhar Danish Ahmad, Subur W. Khan, S. Ali, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Toward the Discovery of a Novel Class of Leads for High Altitude Disorders by Virtual Screening and Molecular Dynamics Approaches Targeting Carbonic Anhydrase
Amena Ali, Abuzer Ali, Musarrat Husain Warsi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5054-5054
Open Access | Times Cited: 16
Leveraging decagonal in-silico strategies for uncovering IL-6 inhibitors with precision
Akey Krishna Swaroop, P. K. Krishnan Namboori, M. Esakkimuthukumar, et al.
Computers in Biology and Medicine (2023) Vol. 163, pp. 107231-107231
Closed Access | Times Cited: 9
Effectiveness of estrogen and its derivatives over dexamethasone in the treatment of COVID-19
Darakhshan Parveen, Anwesha Das, Shaista Amin, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1858-1874
Closed Access | Times Cited: 8
Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro
Min Zhang, Liting Liu, Yao Zhao, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies
Rahman Abdizadeh, Farzin Hadizadeh, Tooba Abdizadeh
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 13, pp. 5915-5945
Closed Access | Times Cited: 12
In Silico Design of New Dual Inhibitors of SARS-CoV-2 MPRO through Ligand- and Structure-Based Methods
Alessia Bono, Antonino Lauria, Gabriele La Monica, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8377-8377
Open Access | Times Cited: 5
Discovery of potential RSK1 inhibitors for cancer therapy using virtual screening, molecular docking, molecular dynamics simulation, and MM/GBSA calculations
Sevil Kalın, Ferah Cömert Önder
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-21
Open Access | Times Cited: 5
Bioactive metabolites of licorice and thyme as potential inhibitors of Cox1 enzyme of phytopathogens of Capsicum annuum L.: In-silico approaches
Himanshu Arora, Gourav Choudhir, Arunava Sengupta, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access | Times Cited: 1
Phytoconstituents of Citrus limon (Lemon) as Potential Inhibitors Against Multi Targets of SARS‐CoV‐2 by Use of Molecular Modelling and In Vitro Determination Approaches
Kannan Raman, Kalirajan Rajagopal, Fahadul Islam, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 1
A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 4
Tinospora cordifolia ameliorates paclitaxel-induced neuropathic pain in albino rats
Priyanka Joshi, Saraswati Patel, Ajita Paliwal, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117559-117559
Closed Access | Times Cited: 3
Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets
Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2427-2427
Open Access | Times Cited: 7
Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT
Ysaías J. Alvarado, Yosmari Olivarez, Carla Lossada, et al.
Computational Biology and Chemistry (2022) Vol. 99, pp. 107692-107692
Open Access | Times Cited: 5
Exploring Scoring Function Space: Developing Computational Models for Drug Discovery
Gabriela Bitencourt‐Ferreira, Marcos A. Villarreal, Rodrigo Quiroga, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 17, pp. 2361-2377
Closed Access | Times Cited: 2
Ehretia Species Phytoconstituents as Potential Lead Compounds against Klebsiella pneumoniae Carbapenemase: A Computational Approach
Samson O. Oselusi, Nicole Remaliah Samantha Sibuyi, Mervin Meyer, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 2
Pressure-induced magnetic phase and structural transition in SmSb2
Tao 涛 Li 李, Shuyang 舒阳 Wang 王, Xuliang 绪亮 Chen 陈, et al.
Chinese Physics B (2024) Vol. 33, Iss. 6, pp. 066401-066401
Closed Access
Page 1 - Next Page

Scroll to top